Cargando…
Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5
Taurochenodeoxycholic acid (TCDCA) is one of the main components of bile acids (BAs). TCDCA has been reported as a signaling molecule, exerting anti-inflammatory and immunomodulatory functions. However, it is not well known whether those effects are mediated by TGR5. This study aimed to elucidate th...
Autores principales: | Qi, Youchao, Shi, Linkai, Duan, Guozhen, Ma, Yonggui, Li, Peifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659238/ https://www.ncbi.nlm.nih.gov/pubmed/34885648 http://dx.doi.org/10.3390/molecules26237066 |
Ejemplares similares
-
The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
por: Qi, Youchao, et al.
Publicado: (2022) -
Transcriptome investigation of anti‐inflammation and immuno‐regulation mechanism of taurochenodeoxycholic acid
por: Bao, Lige, et al.
Publicado: (2021) -
Taurochenodeoxycholic Acid Inhibited AP-1 Activation via Stimulating Glucocorticoid Receptor
por: Li, Lei, et al.
Publicado: (2019) -
Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma
por: Song, Won-Suk, et al.
Publicado: (2018) -
Metabolomic and lipidomic studies on the intervention of taurochenodeoxycholic acid in mice with hyperlipidemia
por: Cui, Na, et al.
Publicado: (2023)